CHOP study reveals patients with eosinophilic esophagitis alter their eating behaviors to increase both chewing time and meal consumption time.

In the largest study of its kind, CHOP researchers have validated a population-level pattern of pediatric allergy development known as the “allergic march.”

Two recent studies show dupilumab improves eosinophilic esophagitis symptoms and pathology for adolescents and young adults.

Bench-to-bedside research supports GI innovation at CHOP.

Personalized therapeutic approaches for children with eosinophilic esophagitis are gaining ground at CHOP.

CHOP researchers discover using FLIP in pediatric patients with achalasia significantly improves esophagogastric junction dysfunction and improves quality of life.

During our annual EoE Education Day, patients and families participated in an exciting day featuring research updates, expert panels, interactive sessions and much more.

CHOP researchers found a simple assay using a blood sample could identify EoE milk allergy with accuracy and sensitivity.

The diagnosis and treatment of eosinophilic esophagitis is often very challenging, requiring management from multiple subspecialties. 

CHOP allergist presents on treatments for children with eosinophilic esophagitis.